Advances in gene discovery methodologies and the analysis of samples from large cohorts of families have rapidly increased our knowledge of the number of genes that cause mental retardation. To date, over 80 genes on the X chromosome have been identified where a mutation results in a syndromic or non-syndromic form of the disease. Although the X chromosome may harbour a disproportionate number of genes for intellectual development, nonetheless, it is likely that more than 1400 genes on the autosomes also give rise to mental retardation. To date, more syndromic forms of MR have been identified compared to non-syndromic forms due to ascertainment bias but with the advent of high resolution aCGH and autozygosity mapping the number of identified autosomal genes that cause disease is likely to grow. The biological mechanism by which each gene causes disease is still poorly understood and examples of proteins that control chromatin remodeling, nonsense mediated decay, post-translational modification of proteins or intracellular trafficking have all been described. This suggests that a mental retardation phenotype may reflect a generalized dysfunction of neurons rather than abnormalities of a few specific pathways required for intellectual processing and thus the understanding of the biological basis of this disease remains a substantial challenge.
functioning (criterion A) that is accompanied by limitations in adaptive functioning in at least 2 key skill areas (criterion B) and the onset must occur before age 18 years (criterion C). General intellectual functioning is defined by the intelligence quotient, IQ. Adaptive functioning refers to how effectively individuals cope with common life demands. In Europe, the ICD-10 Classification of Mental and Behavioural Disorders, World Health Organization (WHO), Geneva 1992 is used whilst in the USA the DSM-IV diagnostic classification is used which is broadly similar to the WHO classification [1, 2] .
Evidence for Single Genes
The observation that intellectual processing, as defined by the intelligence quotient (IQ) in humans, is affected by the genetic status of the individual has been recognized since establishing that Down syndrome is due to an additional chromosome complement [3] . Not until the 1970s was it recognized that in some families the intellectual impairment was not due simply to the side effect of a generalised metabolic abnormality, as seen in the paediatric metabolic abnormalities but rather that there may be specific genes in the genome that only manifest as intellectual impairment in affected individuals. In this chapter, the historical evidence for single gene involvement in MR is presented followed by a description of the actual identification of causative genes and a discussion of the current status of knowledge regarding such genes. Next, the effects of gene dosage are addressed as well as the clinical impact for patients and families that mutation detection brings. Finally, the classification of causative genes is discussed together with biological pathways that may be implicated in MR.
The idea that intellectual impairment in some families was not due to the side effect of a generalised metabolic abnormality led to the concept that some genes, when abnormal, cause non-syndromic mental retardation [4] . A further suggestion that single genes may contribute to intellectual disability were the reports of a number of families where the intellectual disability in the family was unusually common and was transmitted as a Mendelian disorder. In many cases the trait was inherited as an X-linked recessive condition where males were more frequently affected than females. In 1943 Martin and Bell reported a family with an X-linked mental retardation that was later known as Fragile X syndrome [5] . By collecting together families with this disease the concept of anticipation was established where the severity of the intellectual impairment appeared to be more severe as the generations go down, this became known as the Sherman paradox. The observation of a recurrent cytogenetically visible fragile site at Xq27.3 in children with mental retardation and the subsequent collecting together of affected cases from families for linkage studies, led to the eventual identification of the molecular basis of Fragile X syndrome in 1991 [6] .
In the 1970s Lehrke proposed that single gene abnormalities on the X chromosome may be a significant cause of intellectual impairment based on the observation that the ratio of males to females reported with the condition was 1.3:1. The hypothesis was that the excess of males with the disease was due to the manifestation of X-linked disease causing mutations [7] . The ratios were established by LS Penrose in 1938 who performed a systematic study of individuals with intellectual impairment living in a long-term psychiatric institution and documented the family history and diagnosis in each individual [8] . The ratio of 1.3:1 has since been corroborated by many other studies and the proposed hypothesis was reinforced by the identification of the gene, FMR1, that causes Fragile X syndrome in 1991 [6, 9] .
The concept that single genes have their main effect on intellectual processing alone was thus established although it was noted that many of the children with Fragile X syndrome also had some additional features such as a large prominent jaw, large ears, macro-orchidism, scoliosis and occasionally congenital heart disease [10] . This led to the concept of syndromic and non-syndromic mental retardation. Initially this concept was useful experimentally to aid any clustering of affected cases in the attempts to perform linkage analysis to locate the causative gene abnormality but more recently the concept has been less useful since the recognition that the same gene or even the same mutation in a gene can result in either a syndromic or a non-syndromic form of the disease. An example of this is the Aristalessrelated paired-class homeobox (ARX) gene where the same 24-bp insertion duplication within exon 2 is found both in patients with non-syndromic X-linked mental retardation (NS-XLMR), and in the syndromic X-linked West syndrome (characterized by infantile spasms, hypsarrhythmias and MR) and Partington syndrome (an extrapyramidal neurological disorder characterized by dystonic movements of the hands, dysarthria and MR) [11, 12] . It has been suggested that the phenotypic heterogeneity caused by the same mutation in different families could be due to differences in genetic and environmental backgrounds that are specific to each family [12] . Further examples of mutations at the same locus giving rise to both syndromic or non-syndromic disease, include mutations within MECP2 (Rett syndrome), RPS6KA3 (Coffin-Lowry syndrome) and ATRX (α-thalassaemia mental retardation syndrome, X-linked) [13] [14] [15] [16] [17] [18] . The mutations in these genes in NS-XLMR families are presumed to cause only a partial loss of function of the encoded proteins, which could explain the absence of syndromic features [19] .
Since the late 1980s many families with mental retardation who did not have Fragile X syndrome, had been reported and many have had linkage analysis performed to identify where on the X chromosome the gene of interest lay. The concept of MRX and a numbering system for each family, MRX1-MRX82 was established in order to register each family where the LOD >2 was demonstrated (http://www.rm.unicatt.it/ xlmr/) [20] . It was initially assumed that approximately 10-12 genes located on the different parts of the chromosome caused disease as linkage for each family fell into one of each of the discrete regions [19] .
Identification of MR Genes
The advent of improved gene mapping tools such as bacterial artificial chromosomes (BACs) from the Human Genome Project meant that a number of single genes were identified in individuals with cytogenetic abnormalities including overlapping deletions or X;autosome translocations in females. Six genes (TSPAN7, ZNF41, ZNF81, OPHN1, AGTR2 and ARHGEF6) were identified after being mapped to an X chromosome breakpoint in an individual with an X;autosome translocation and non-syndromic mental retardation [21] [22] [23] [24] [25] [26] . Notably, for 5 out of 6 of these genes the patients with a balanced translocation were females (males with balanced X;autosome translocations are rare as most de novo X;autosome translocations are paternal in origin [27] ). The identification of these disrupted genes did not identify a second common mental retardation gene comparable in frequency to Fragile X syndrome, but rather it appeared that for each new gene identified, the number of families with an abnormality in that gene was very few.
Since 2000, the rate of identification of novel genes that cause mental retardation has progressed rapidly due to technological developments [28] . Prior to this, most gene identification methods relied on linkage and positional cloning methodologies. This meant that only large kindreds were amenable to study. In each large family, the candidate interval for the disease causing gene was found by identifying which parts for the X chromosome was shared by all the affected males and not shared by the unaffected males in the family. The larger the family, the smaller the linkage interval can be potentially determined. As X-linked mental retardation is so genetically heterogeneous, linkage data from multiple families could not be pooled and each family needed to be maintained as a separate linkage interval. This meant that frequently, only large linkage intervals were available for a study and multiple small pedigrees were not useful for gene identification methods. Progress was achieved by improved DNA sequencing methods and the coordination of 2 large international studies to identify the causative genes, EURO-MRX and IGOLD. The EURO-MRX group analysed a region of Xp11 in detail and identified 3 further genes that cause MR [29] [30] [31] . The IGOLD group have recently taken a systematic approach to interrogate all the coding sequences on the X chromosome (>700 genes) in a cohort of 206 families with evidence of X-linked mental retardation. This has been successful and has identified >10 further novel disease causing X-linked genes [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] .
Current Status of Genes that Cause MR
Since the recent completion of the X chromosome re-sequencing project many genes on the X chromosome are now associated with mental retardation [37] . The current estimate is that >70 genes on the X chromosome when mutated give rise to a syndrome with associated MR or a non-syndromic form of the disease. This represents approximately 10% of the genes on the X chromosome. This raises the question as to whether there is something unusual about the X chromosome that it harbours so many genes on the chromosome that are involved with intellectual processing [42] . The alternative hypothesis is that the genes identified on the X chromosome merely reflect the experimental ascertainment bias of using X-linked pedigrees as a tool for gene discovery and that there is nothing especially unusual about the function of genes on the X chromosome. If true this would predict that the number of genes on autosomes that have the potential to cause mental retardation is in proportion to the number of genes on the X compared to that on autosomes. A crude estimate is that there are a further 20 × 70 = 1400 genes or greater on the autosomes that cause MR. Based on entries on OMIM (Online Mendelian Inheritance in Man http://www.ncbi. nlm.nih.gov) which is another crude way of estimating the number of genes on autosomes that cause syndromic or non-syndromic MR, there are 1557 entries for mental retardation of which 293 relate to the X chromosome and 1244 (80%) are autosomal locations. Until recently, only a handful have been identified where non-syndromic mental retardation is the predominant feature whereas by far the majority are associated with a syndrome [43] [44] [45] .
The paucity of autosomal genes that have been identified associated with non-syndromic MR is likely to be due to a number of factors. Firstly, the number of familial conditions reported clinically with mental retardation as the predominant feature is heavy weighted towards cases caused by single gene defects on the X chromosome. The ascertainment may be due to the identification of pedigrees with multiple affected individuals over several generations. Severe mental retardation is associated with lower reproductive function and thus is frequently a reproductive lethal condition.
Pedigrees where multiple affected individuals are identified are more common in X-linked recessive diseases due to the relatively milder effect in females. Autosomal dominant pedigrees of a high penetrance disease gene are unlikely to be present in the population due to the affected individuals not reproducing. Singletons with new dominant diseases are rarely identified from pedigrees, as the pedigrees are indistinguishable from singleton affected children due to multiple possible causes. Similarly, autosomal recessive families will only be identified if there are more than one affected individual in a single generation. This is more likely to occur in families where consanguinity is common and many of the recently identified genes that cause autosomal recessive disease have been enriched from families living within cultures where consanguineous marriages are common [46] [47] [48] . For autosomes where a single new mutation occurs, the clinical manifestation of the disease will only occur if the effect of the mutation is a dominant trait. Traits that function as recessive diseases will only manifest clinically when there are 2 abnormal alleles on the autosomes, compared to X-linked diseases where only an abnormality of one allele is sufficient to cause the disease in males. It may be for these relatively simple reasons that so few autosomal genes have been defined for non-syndromic mental retardation so far. Nevertheless, the wealth of disease genes that are associated with syndromic forms of mental retardation on autosomes such as Angelman syndrome (UBE3A), Rubinstein Taybi (CREBBP), 9q34 syndrome (EHMT1), Smith-Magenis syndrome (RAI1) and Mowat-Wilson (ZEB2), illustrate the many and various ways in which mental retardation is manifest as a phenotype of cellular malfunction.
However, there are also arguments suggesting that there may be fewer autosomal genes that cause MR than predicted, as the X chromosome has gradually acquired a disproportionate number of genes that function in intellectual function. Recombination events on the X chromosome in humans are limited to occasions where pairing occurs. This by definition is limited to females except for the pseudoautosomal region of the X. This means that the rate of loss or gain of genes by recombination once they arrive on the X chromosome is slower than for autosomes. However, the rate of movement of the genetic code on and off the X chromosome is higher than for autosomes. These movements are mediated by transposons derived from the X chromosome which move X chromosome material off the X chromosome but also autosome derived transposons that mediate movement of autosome material onto the X chromosome [49, 50] . One hypothesis is that once genes arrive on the X chromosome the chance of them moving off again is lower. Positioning a gene on the X chromosome allows the sequence to evolve a new function in a relatively protected environment and hence the acquisition of genes important for brain function are concentrated on the X chromosome, many of which are derived from ancestral genes that had a testes specific function previously.
With the advent of array comparative genomic hybridization (aCGH) as a routine investigation of children with developmental delay it is likely that many more autosomal regions will be identified that contain genes that give rise to mental retardation. Mechanisms by which this will occur are haploinsufficiency alone or by unmasking a recessive condition or by microduplication of single or multiple genes in combination. The latter are discussed in more detail in chapter 10. Together with the progress in high throughput sequence analysis the possibility now arises of identifying many more single genes that cause mental retardation both on the autosomes and the few remaining on the X chromosome in the near future.
From the genes we have identified to date, various patterns are coming to light as to the nature of the disease mechanisms and some interesting principles are emerging. Firstly, there are a high number of genes that cause mental retardation, far higher than predicted initially. Loss of function mutations in a large number of genes give rise to mental retardation suggesting that the brain, both in its development and maintenance, is exquisitely sensitive to alterations of gene expression and function and the resultant abnormality is expressed as mental retardation. This also reflects the clinical paucity of discriminatory tools we currently have to distinguish phenotypically the different sorts of intellectual deficit where the intellectual abnormality is associated with a low IQ of 50-70. It also indicates that it may be that the multiple aberrations of different genes that are described result in a relatively similar outcome, namely that of intellectual difficulties. This implies that brain function is carefully regulated and easily disturbed. Monogenic diseases are usually associated with dramatic loss of function of the gene products. Whilst finding a mutation in a gene does not necessarily mean that this protein has a critical or rate limiting role in normal function of the brain, it certainly indicates that the absence of this protein is devastating and that the normal wild-type protein does have some functions in maintaining normal intellectual processing. The genes that have been identified to date on the X chromosome act as a form of pilot study for the number and type of genes that give rise to MR in the whole genome.
It is likely that many or most of the genes that have been identified to date either interact or interconnect through as yet unidentified molecules. Identifying the key genes and abnormalities that cause mental retardation permits the functional importance of other genes to be predicted for MR by understanding the biological networks of interactions of each component of the network.
The evidence that specific genes that have been identified actually cause disease is somewhat variable. With the advent of high throughput sequencing technology it is becoming clear that the presence of a single rare variant or the presence of a single deletion of a whole gene does not necessarily implicate this gene in the causation of mental retardation [37] . Only where there are multiple deleterious sequence variants found in separate cases of mental retardation and where the variants are not found in a similarly large set of control samples can the gene be assigned confidently to a mental retardation phenotype.
Single Gene Dosage
For some genes there is a correlation between disease severity and the pathogenicity of the mutation. Mutations in MECP2 give rise to a range of disorders depending on how severely the protein is affected or how many copies of the genomic sequence are present. Loss of function mutations are usually lethal in males although some children have been born with a severe encephalopathy with early death. Truncating and missense mutations in females are viable and are associated with Rett syndrome whilst only missense mutations have been described in males with severe mental retardation or PPM-X syndrome [17, 51, 52] . More recently, duplications of the gene have been associated with a severe mental retardation syndrome in males accompanied by a predisposition to severe infections reflecting the axiom that duplication of genes are frequently less detrimental than deletions [53] . It is possible that even milder mutations of MECP2 will be associated with a milder phenotype that has yet not been described. This genotype-phenotype correlation is also illustrated in the mutation spectrum found in RSK2 (RPS6KA3) and ATRX [18, 54] . In RSK2 (RPS6KA3), four mild mutations with a single amino acid deletion or missense mutation in a functionally less important region of the protein have now been described that are associated with mental retardation alone and not the typical clinical features of Coffin Lowry syndrome. Similarly, not all children with a mutation in ATRX have the classical clinical features of ATRX syndrome, but some are only identified as having a non-syndromic mental retardation. There are other X-linked genes where the presence of truncating mutations in males is thought to be lethal and only missense mutations are observed in a population of families with mental retardation. This has been recently seen in CASK [37, 55] .
The logical extension of these observations is that genes cause disease in a continuum from fully penetrant mutations, causing monogenic disease, through to alleles that are only usually penetrant. These lower penetrant alleles will nevertheless predispose to disease in association with one or two other specific alleles giving rise to an oligogenic model of disease. Disease could also arise through alleles that only cause disease in association with other predisposing alleles in a truly polygenic model of disease, where the number or alleles that associate to give rise to disease is high. One possible example of this phenomenon is the identification of whole gene deletions in the VCX complex on Xp that is associated with intellectual impairment in some and completely normal intelligence in others but the mechanism whereby deletions of VCX cause disease is still not fully understood [56, 57] .
Clinical Implications of Mutation Detection
The benefits of identifying genes that cause mental retardation are many. From the families' perspective the identification of a genetic cause of disease can often give a final explanation for why their son or daughter has a disability. Parents often feel partially responsible for what has happened to their child and question whether the disability was due to something they did or did not do during pregnancy or during the early years of parenting. For most, just knowing that there is a gene mutation that causes the disease is of some therapeutic benefit in terms of preventing further unnecessary investigations in the child and in terms of resolving the uncertainty of not knowing the cause of disease. It can also help the wider family come to terms with the diagnosis. For some family members the identification of a mutation in an affected individual means that the risk to other family members can be accurately assessed. For X-linked conditions predictive testing can be made available to female relatives to determine their carrier status. Since the identification of a number of genes that cause MR, we have observed significant changes in the reproductive habits of families who have had the genetic cause identified in their family. Turner et al. (2008) observed that when families know they are at risk of having a child with an X-linked intellectual disability syndrome, the women at risk have fewer children than predicted based on the population rate of reproduction [58] . Once a gene abnormality is identified, the at-risk women rapidly come forward for predictive testing and have children. For those who do not have the mutation no further prenatal assessment is done, but for those who find they are carriers of an X-linked disorder some, though not all, use prenatal testing of males as a means of achieving a family whereas others continue to have children or elect to have none.
Classification of Single Genes and Biological Mechanisms that Cause MR
One of the assumptions of identifying gene abnormalities on the X chromosome was that the genes would indicate universal pathways and insight into the biological mechanisms of mental retardation. As the discovery of genes has progressed the idea that there are key common pathway disturbances that result in MR has become gradually less clear. It is emerging that mental retardation can result from abnormalities of genes that function in almost any biological process that the cell conducts. Standard text books in cell biology commonly divide the different functions within the cell into chapters [59] . These functions include: DNA and chromosomes, DNA replication repair and recombination, how cells read the genome (from DNA to protein), control of gene expression, membrane structure, membrane transport of small molecules and the electrical properties of membranes, intracellular compartments and protein sorting, intracellular vesicular traffic, energy conservation: mitochondria, cell communication, the cytoskeleton, cell cycle and programmed cell death and the mechanics of cell division. To date, we now have defined mutations in genes coding for proteins that function in each of these various cellular processes except mitochondrial function suggesting that the phenotype of mental retardation is the final common manifestation of neurons that are functionally ineffective by a wide range of nonspecific means (table 1) .
Perhaps not surprisingly, proteins that regulate global cellular functions such as DNA folding, chromatin remodelling and transcription factors represent the most common class of proteins although one might predict that defects in such fundamental cellular processes would be lethal and it appears that many of these only give rise to a phenotype of mental retardation presumably due to functional redundancy of the various transcription factors. Structural components of the post-synaptic membrane such as NLGN4, CASK, DLG3 are clearly critical for normal function of specialized neuronal cells and many mutations in these components are described. A less predictable class of abnormality are those that cause mental retardation by disrupting protein trafficking such as AP1S2 which acts as a structural component of the AP1 complex whose role is to bind vesicle cargo proteins in endosomes and trans-Golgi network. The pathology here is likely to be the failure of delivery of appropriate cellular components within specialist cells rather than abnormalities in the components themselves. Similarly, defects in ZDHHC9 cause disease by altering the post translational modification of its target protein by palmitoylation. It is known that at least one of the targets for ZDHHC9 is RAS protein and alterations of the palmitoylation of this protein determines both the intracellular distribution of RAS protein within the cell and the time spent at the plasma membrane or the Golgi complex [60] . Intracellular signalling molecules especially those involved in GTP coupled signalling seem to be especially important (GDI1, PAK3, ARHGEF6) although mutations in extracellular communication proteins (TSPAN7) are also observed. Defects in the cell cycle have not been described in non-syndromic mental retardation per se, but patients with associated features of microcephaly or poor growth and visual defects as seen in Cockayne syndrome are all associated with significant intellectual impairment suggesting that brain development and function is as sensitive to cell cycle defects as cells within the body that undergo multiple cell divisions.
Conclusion
In summary, over the last 30 years the number of genes that have been identified that cause mental retardation has been astonishing and is far more than the earlier literature ever predicted. The X chromosome has been heavily mined and mutations in any one of ~10% of the coding genes on the X chromosome is now associated with disease. If the X chromosome acts as a model of the genome the prediction is that more than 1400 human genes can cause disease in a monogenic model of disease. Given that 0.5% of the population has severe mental retardation it is possible that, although pure speculation at this stage, most cases of mental retardation are due to abnormalities in single genes somewhere on the genome. None of the other common genetic diseases described such as diabetes mellitus, cardiovascular or inflammatory bowel disease appear to have this feature. Currently, there is no specific word used for this pattern of disease causation where multiple monogenic disease genes contribute to disease but multi-monogenic might be appropriate. The task for the next generation of research now needs to be focused on identifying the remaining elusive genes that cause mental retardation especially on the autosomes but also more challenging is trying to understanding the various and complex mechanisms by which these gene abnormalities actually cause disease. It is only once we have a better understanding of the disease processes of individual genes that we can consider possible therapeutic strategies that will ameliorate the disease state for the few patients identified with that specific disease abnormality.
